Neurological Disorder Diagnostics Market Research Insights 2024 - 2030
The report "Neurological Disorder Diagnostics Market by Component (Instruments, Reagents, and Kits, Software, and Services), by Technology (Immunoassay, PCR Techniques), by Disease Type (Alzheimers disease, Dementia, Parkinson's Disease, Epilepsy, Traumatic Brain Injury, Others), by End User (Hospitals and Clinics, Diagnostic Centers, Academic, and Research Institutes) - Global Forecasts to 2030" The global Neurological Disorder Diagnostics Market is projected to reach USD 16630. 1 million in 2023, registering at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period 2024-2030. The growth of the market is majorly driven by growing adoption of novel diagnostic technologies. Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=35761 Competitive Dashboard: The prominent key players operating in the global Neurological Disorder Diagnostics Market are Hoffmann La Roche Ltd. Creative Biolabs Diadem Srl Fujirebio Diagno...